{"schema_version":"secwatch.filing_event.v1","accession":"0001688757-24-000022","form_type":"8-K","ticker":"ESTA","cik":"0001688757","company_name":"ESTABLISHMENT LABS HOLDINGS INC.","filed_at":"2024-02-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.120823+00:00","generated_at":"2026-06-05T09:04:20.433476+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Establishment Labs Q4 revenue falls 28% YoY to $31.6M; guides 2024 rev up 5-11% to $174-184M","bullets":["Q4 revenue $31.6M vs $43.8M prior year; net loss from operations $22.1M vs $13.2M.","Adjusted EBITDA loss of $17.3M in Q4 vs $8.9M loss a year ago.","2024 revenue guidance $174-184M (+5-11%); excludes US Motiva Implants revenue expected in 2024.","Proforma cash $90M after Jan $50M private placement; Oaktree facility amended for up to $50M post-FDA approval.","Launched Motiva Implants in China; first US commercial procedure with Motiva Flora tissue expander."],"urls":{"canonical":"https://secwatch.observer/filing/0001688757-24-000022","json":"https://secwatch.observer/filing/0001688757-24-000022.json","markdown":"https://secwatch.observer/filing/0001688757-24-000022.md","text":"https://secwatch.observer/filing/0001688757-24-000022.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1688757/000168875724000022/0001688757-24-000022-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1688757/000168875724000022/esta-20240228.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T09:04:20.433476+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1549985a60c84d76734068ca9bb315348fe1333b","claim":"ESTABLISHMENT LABS HOLDINGS INC. reported Fourth Quarter 2023 results: net income $22.1 million net loss.","evidence_excerpt":"Fourth quarter net loss from operations of $22.1 million compared to a net loss of $13.2 million in the year-ago period.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1688757/000168875724000022/0001688757-24-000022-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Fourth Quarter 2023"},{"label":"Net income","value":"$22.1 million net loss"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"57e6901c4535b21cc91c38c74c80dfa36455c0c8","claim":"ESTABLISHMENT LABS HOLDINGS INC. reported Fourth Quarter and Full Year 2023 results: revenue $31.6 million.","evidence_excerpt":"Total revenue for the quarter ended December 31, 2023 was $31.6 million compared to $43.8 million for the same period in 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1688757/000168875724000022/0001688757-24-000022-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Fourth Quarter and Full Year 2023"},{"label":"Revenue","value":"$31.6 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"8d4d5e98ae0d44feb8b9affe0305508316b08dbb","claim":"ESTABLISHMENT LABS HOLDINGS INC. reported 2024 results: revenue $174 million to $184 million. Guidance reaffirmed.","evidence_excerpt":"2024 revenue guidance of $174 million to $184 million, an increase of 5% to 11% over 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1688757/000168875724000022/0001688757-24-000022-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"2024"},{"label":"Revenue","value":"$174 million to $184 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}